Hyllengren Eric J

EVP, CFO and COOAtara Biotherapeutics, Inc. (ATRA) · full profile →Form 4 · filed Nov 20, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$15K
Net Open-Market Flow
-$15K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 18, 2024Sell(S)1K$11.20$15K23K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000905148-24-003242) within minutes of acceptance. Every field above traces to the original document. Verify it directly: